Depressed adjuvant arthritis in chronically Trypanosoma cruzi infected rats: reversal by cyclophosphamide

J Rheumatol. 1992 Apr;19(4):513-6.

Abstract

Chronically Trypanosoma cruzi infected "I" rats and syngeneic naive recipients, transferred with a T cell enriched spleen cell population from infected donors, develop an attenuated arthritis when challenged with complete Freund's adjuvant. We report that cyclophosphamide, 40 mg/kg body weight, given 48 h before induction, was able to reestablish or exacerbate adjuvant arthritis in infected and control rats, respectively. Although the T cell enriched spleen cells from infected donors continued to down regulate adjuvant arthritis in syngeneic recipients given cyclophosphamide 48 h before cell transfer, treatment of infected donors with cyclophosphamide, 48 h before cell collection, prevented these cells from exerting such effect when transferred to healthy recipients receiving no cyclophosphamide. It is suggested that cyclophosphamide may primarily affect a suppressor cell population, present in the infected host, with regulatory activity on adjuvant arthritis.

MeSH terms

  • Animals
  • Arthritis, Experimental / microbiology*
  • Chagas Disease*
  • Chronic Disease
  • Cyclophosphamide / pharmacology*
  • Immunotherapy, Adoptive
  • Male
  • Rats
  • Spleen / cytology
  • Spleen / physiology
  • T-Lymphocytes / physiology
  • Trypanosoma cruzi

Substances

  • Cyclophosphamide